Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Magnetic stimulation shows promise for depression:

This article was originally published in Clinica

Executive Summary

Repetitive transcranial magnetic stimulation (rTMS), a treatment for severe depression that involves delivering brief intense magnetic pulses to the brain, may provide a promising alternative to electroconvulsive (ETC) therapy, according to data due to appear in an upcoming issue of Biological Psychiatry. In a study of 25 patients, researchers found that both therapies produced significant improvement in symptoms. However, rTMS appeared to produce fewer harmful side effects than ETC therapy, said study researcher Philip Janicak, of the University of Illinois at Chicago.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064578

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel